Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.
Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H. · 2007
Read Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. by Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2360429.txt.
Description
Osterlund and co-authors ran a randomised trial of a probiotic during colon cancer chemotherapy in 2007. Probiotics are live bacteria taken for gut health. The drug 5-fluorouracil, a mainstay after colon cancer surgery, often causes severe diarrhoea that forces dose cuts.
The trial enrolled 150 patients on two versions of the drug plan for 24 weeks. Half also got daily Lactobacillus rhamnosus GG, a probiotic strain, plus fibre. Severe diarrhoea struck 22% of the probiotic group versus 37% of the others, and they needed less hospital care. Added fibre alone changed nothing. One drug schedule, the simplified de Gramont plan, caused far fewer severe side effects overall, at 45% versus 89% for the monthly Mayo plan.
Catalog record
| CREATOR | Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |